EQS-AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements ...

Evotec announces key progress in neuroscience collaboration with Bristol Myers Squibb: Hamburg, Germany Wednesday, March 5, 2025, 13:00 Hrs [IST] Evotec SE, a life science company ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025 Paul Hitchin appointed to succeed as Chief ...

Update 1:50pm: Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer.

Evotec SE press release (NASDAQ:EVO): FY Revenue of €781.4M (+4.0% Y/Y). Adjusted Group EBITDA at €66.4M (2022: €101.7M), adjusted for one-off effects related to the recovery from the severe ...

Explore Evotec stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EVO. Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth Outlook Halozyme ...

Evotec SE, the Hamburg-based pharmaceutical research company, is undergoing significant leadership transitions as it navigates through challenging market conditions. The company announced that current ...

The collaboration has already yielded strong results, including the in-licensing of EVT8683 (now BMS-986419) by Bristol Myers Squibb in September 2021. In March 2023, the companies reaffirmed their ...

HAMBURG, GERMANY / ACCESS Newswire / February 26, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its Chief Financial Officer ...

Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Ev ...